Compare GOSS & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GOSS | IROQ |
|---|---|---|
| Founded | 2015 | 1883 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.2M | 91.6M |
| IPO Year | 2018 | 2011 |
| Metric | GOSS | IROQ |
|---|---|---|
| Price | $0.43 | $26.55 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $4.91 | N/A |
| AVG Volume (30 Days) | ★ 25.1M | 21.7K |
| Earning Date | 03-17-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.48% |
| EPS Growth | N/A | ★ 140.35 |
| EPS | N/A | ★ 0.84 |
| Revenue | ★ $48,471,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $31.61 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.33 | $23.01 |
| 52 Week High | $3.87 | $29.00 |
| Indicator | GOSS | IROQ |
|---|---|---|
| Relative Strength Index (RSI) | 23.44 | 34.35 |
| Support Level | $0.33 | $23.86 |
| Resistance Level | $0.60 | $26.99 |
| Average True Range (ATR) | 0.06 | 0.23 |
| MACD | 0.06 | -0.15 |
| Stochastic Oscillator | 22.86 | 2.98 |
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
IF Bancorp Inc is a holding company mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company, in association, takes deposits from the general public and invests those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, etc., and offers a variety of deposit accounts and alternative delivery channels. In addition to the traditional banking products and services, the group also offers a full line of property and casualty insurance products, annuities, mutual funds, individual securities, managed accounts, and other financial services.